Tag Archives: business model

Warning: Don’t Let Bio-Euphoria Distract You from Being Disciplined


This piece by Allan L. Shaw was originally published in Life Science Leader. We currently in a period I call “bio-euphoria,” in which the biopharmaceutical industry is experiencing growth in almost every area from market performance to patient-focused legislation. In parallel to this positive momentum, there has also been a notable shift in management and operational strategy by Big Pharma companies in an attempt to keep evolving with the market. These companies are taking creative Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , ,

For U.S. Healthcare Reform and Global Health Crises, Both Public and Private Efforts Needed

How can we address health needs in both the United States and developing countries at the same time? By bringing everyone to the table for open, fair, collaborative partnerships. It saves money, time, effort and – most important of all – lives.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Is the FTC well-suited to take on IP/Patent policy?

On December 5, 2008 the Federal Trade Commission held the first in a series of hearings entitled: The Evolving IP Marketplace. According to the FTC, the hearings are intended to examine changes in intellectual property law and patent-related business models since the FTC issued its October 2003 report, entitled To Promote Innovation: The Proper Balance of Competition and Patent Law and Policy A Report by the Federal Trade Commission. December 5th’s hearing featured CAFC Chief Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,